Recent Finacing
Recent Raise
OLGRAM develops marine-derived peptides and a marine sulfated polysaccharide to target dormant persister bacteria causing chronic relapsing infections, initially focusing on Pseudomonas in cystic fibrosis and nosocomial infections.
